LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) has rescheduled its shareholder update conference call to April 23, 2026, at 4:30 p.m. ET, as it revises financing plans tied to a proposed transaction with Celularity Inc.
The company said it will no longer finance the potential Celularity transaction under a previously announced securities purchase agreement with an institutional investor and is negotiating a new financing structure with a different group of investors.
NEXGEL expects to provide additional details about the proposed Celularity transaction during the April 23 call.
The shareholder update call will be accessible by phone at 1-800-267-6316 in the United States or 1-203-518-9783 internationally.
A live webcast will be available at https://ir.nexgel.com/news-events/events-presentations.
NEXGEL develops and manufactures high-water-content hydrogel products used in healthcare, beauty, and over-the-counter applications, and maintains contract manufacturing relationships with consumer healthcare companies.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.